William Guyer - 28 Feb 2025 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for William Guyer.
Issuer symbol
CORT
Transactions as of
28 Feb 2025
Transactions value $
-$796,200
Form type
4
Filing time
04 Mar 2025, 19:53:01 UTC
Previous filing
04 Dec 2024
Next filing
02 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $385,200 +20,000 +3.64% $19.26 25,487 04 Mar 2025 Direct
transaction CORT Common Stock Sale -$1,181,400 -20,000 -78.47% $59.07 5,487 04 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Award $0 +140,000 $0 140,000 28 Feb 2025 Common Stock 140,000 $60.58 Direct F2
transaction CORT Stock option (right to buy) Options Exercise $0 -20,000 -40% $0 30,000 04 Mar 2025 Common Stock 20,000 $19.26 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction.
F2 Exercise ratably in equal installments on each monthly anniversary of February 28, 2025 over a four-year period subject to the Reporting Person's continued service through each vesting date.
F3 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.